Back

SGO 2023 - Society of Gynecologic Oncology Annual Meeting on Women’s Cancer 2023

Mar 25 - Mar 28, 2023 | TampaFLUS

LARVOL is not affiliated with Society of Gynecologic Oncology Annual Meeting on Women’s Cancer 2023 and all trademarks, logos, and brand names are property of their respective owners

Top Trials

Showing 39 titles linked to Trials

NRG GY018/Keynote-868: A Phase III Randomized, Placebo-Controlled Study of Pembrolizumab in Addition to Paclitaxel and Carboplatin for Measurable Stage III or IVA, Stage IVB or Recurrent Endometrial Cancer

  • Late-Breaking, Plenary
11 Twitter Reactions

Dostarlimab in combination with chemotherapy for the treatment of primary advanced or recurrent endometrial cancer: a placebo-controlled randomized phase 3 trial (ENGOT-EN6-NSGO/GOG-3031/RUBY)

  • Late-Breaking, Plenary
6 Twitter Reactions

2 - Botensilimab, a novel innate/adaptive immune activator, plus balstilimab (anti-PD-1) in patients with recurrent platinum refractory/resistant ovarian cancer

  • Plenary
2 Twitter Reactions